A clinical approach to diagnosis of autoimmune encephalitis F Graus, MJ Titulaer, R Balu, S Benseler, CG Bien, T Cellucci, I Cortese, ... The lancet neurology 15 (4), 391-404, 2016 | 3750 | 2016 |
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study J Granerod, HE Ambrose, NWS Davies, JP Clewley, AL Walsh, D Morgan, ... The Lancet infectious diseases 10 (12), 835-844, 2010 | 1596 | 2010 |
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and … SR Irani, S Alexander, P Waters, KA Kleopa, P Pettingill, L Zuliani, ... Brain 133 (9), 2734-2748, 2010 | 1519 | 2010 |
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both … SR Irani, K Bera, P Waters, L Zuliani, S Maxwell, MS Zandi, MA Friese, ... Brain 133 (6), 1655-1667, 2010 | 1183 | 2010 |
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis SR Irani, AW Michell, B Lang, P Pettingill, P Waters, MR Johnson, ... Annals of neurology 69 (5), 892-900, 2011 | 986 | 2011 |
Autoantibodies associated with diseases of the CNS: new developments and future challenges A Vincent, CG Bien, SR Irani, P Waters The Lancet Neurology 10 (8), 759-772, 2011 | 681 | 2011 |
Morvan syndrome: clinical and serological observations in 29 cases SR Irani, P Pettingill, KA Kleopa, N Schiza, P Waters, C Mazia, L Zuliani, ... Annals of neurology 72 (2), 241-255, 2012 | 569 | 2012 |
Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype SR Irani, CJ Stagg, JM Schott, CR Rosenthal, SA Schneider, P Pettingill, ... Brain 136 (10), 3151-3162, 2013 | 477 | 2013 |
Updated diagnostic criteria for paraneoplastic neurologic syndromes F Graus, A Vogrig, S Muñiz-Castrillo, JCG Antoine, V Desestret, D Dubey, ... Neurology: Neuroimmunology & Neuroinflammation 8 (4), e1014, 2021 | 450 | 2021 |
Disease-relevant autoantibodies in first episode schizophrenia MS Zandi, SR Irani, B Lang, P Waters, PB Jones, P McKenna, AJ Coles, ... Journal of neurology 258, 686-688, 2011 | 389 | 2011 |
The importance of early immunotherapy in patients with faciobrachial dystonic seizures J Thompson, M Bi, AG Murchison, M Makuch, CG Bien, K Chu, ... Brain 141 (2), 348-356, 2018 | 348 | 2018 |
Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management H Abboud, JC Probasco, S Irani, B Ances, DR Benavides, M Bradshaw, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (7), 757-768, 2021 | 328 | 2021 |
Serial anti–myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes P Waters, G Fadda, M Woodhall, J O’Mahony, RA Brown, DA Castro, ... JAMA neurology 77 (1), 82-93, 2020 | 269 | 2020 |
N‐methyl‐D‐aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica RC Dale, SR Irani, F Brilot, S Pillai, R Webster, D Gill, B Lang, A Vincent Annals of Neurology: Official Journal of the American Neurological …, 2009 | 260 | 2009 |
The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data A Al-Diwani, A Handel, L Townsend, T Pollak, MI Leite, PJ Harrison, ... The Lancet Psychiatry 6 (3), 235-246, 2019 | 240 | 2019 |
International multicenter examination of MOG antibody assays M Reindl, K Schanda, M Woodhall, F Tea, S Ramanathan, J Sagen, ... Neurology: Neuroimmunology & Neuroinflammation 7 (2), e674, 2020 | 222 | 2020 |
Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5 MJ McMillin, AE Beck, JX Chong, KM Shively, KJ Buckingham, ... The American Journal of Human Genetics 94 (5), 734-744, 2014 | 213 | 2014 |
A multicenter comparison of MOG-IgG cell-based assays PJ Waters, L Komorowski, M Woodhall, S Lederer, M Majed, J Fryer, ... Neurology 92 (11), e1250-e1255, 2019 | 206 | 2019 |
Antibodies to GABAA receptor α1 and γ2 subunits: Clinical and serologic characterization P Pettingill, HB Kramer, JA Coebergh, R Pettingill, S Maxwell, A Nibber, ... Neurology 84 (12), 1233-1241, 2015 | 205 | 2015 |
Cell‐surface central nervous system autoantibodies: clinical relevance and emerging paradigms SR Irani, JM Gelfand, A Al‐Diwani, A Vincent Annals of neurology 76 (2), 168-184, 2014 | 204 | 2014 |